Locoregional
Showing 1 - 25 of 1,500
Locoregional Recurrence of Breast Cancer
Not yet recruiting
- Locoregional Recurrence
- (no location specified)
Aug 4, 2023
Breast Cancer Trial in Montpellier (Treatment ETHOS radiotherapy, Conventional IMRT)
Not yet recruiting
- Breast Cancer
- Treatment ETHOS radiotherapy
- Conventional IMRT
-
Montpellier, FranceCentre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Sep 19, 2023
Immune Checkpoint Inhibitor Monotherapy or Combined With
Not yet recruiting
- Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
- Immune checkpoint inhibitor
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023
Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,
Not yet recruiting
- Locoregional Recurrence
- +2 more
- Ribociclib
- +4 more
- (no location specified)
Jul 18, 2022
Postoperative Pain, Chronic Post Operative Pain, Breast Tumor Trial in Valence (SIFP Block Locoregional Interfascial Anesthesic
Completed
- Postoperative Pain
- +4 more
- SIFP Block Locoregional Interfascial Anesthesic Technique
- +2 more
-
Valence, Valencia, SpainJosé De Andrés Ibáñez
Jan 10, 2022
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Hepatocellular Carcinoma Trial in Roma (multimodal ultrasound)
Recruiting
- Hepatocellular Carcinoma
- multimodal ultrasound
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Aug 3, 2023
Endodontic Inflammation Trial in Nantes (computerized intraosseous technique (Quicksleeper™), loco-regional anesthesia (IANB
Completed
- Endodontic Inflammation
- computerized intraosseous technique (Quicksleeper™)
- loco-regional anesthesia (IANB technique)
-
Nantes, Loire-Atlantique, FranceNantes Universitary Hospital
Jun 27, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)
Not yet recruiting
- Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Jun 5, 2023
Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and
Not yet recruiting
- Hepatocellular Carcinoma
- Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
- Atezolizumab and bevacizumab
- transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
-
Dallas, TexasSimmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Reduction in Pain Within 24 Hours of Surgery Trial in Montreuil (pudendal block)
Recruiting
- Reduction in Pain Within 24 Hours of Surgery
- pudendal block
-
Montreuil, FranceCamby
Feb 25, 2022
Breast Tumors, Radiotherapy, Lymphedema Trial in Canada (Locoregional radiation treatment - Conventional fractionation,
Recruiting
- Breast Neoplasms
- +2 more
- Locoregional radiation treatment - Conventional fractionation
- Locoregional radiation treatment - Hypofractionation
-
Calgary, Alberta, Canada
- +12 more
May 26, 2022
Hepatocellular Carcinoma Trial in Philadelphia (Hydroxychloroquine, Lipiodol, Placebo)
Not yet recruiting
- Hepatocellular Carcinoma
- Hydroxychloroquine
- +2 more
-
Philadelphia, PennsylvaniaCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Apr 21, 2023
Proton SBRT and Immunotherapy for Recurrent/Progressive
Terminated
- Head and Neck Cancer
- Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
- +3 more
-
Scottsdale, Arizona
- +1 more
Aug 31, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Colorectal Cancer, Sigmoid Cancer Trial in Girona (Complete mesocolon excision, Conventional locoregional lymphadenectomy)
Active, not recruiting
- Colorectal Cancer
- Sigmoid Cancer
- Complete mesocolon excision
- Conventional locoregional lymphadenectomy
-
Girona, SpainUniversity Hospital Dr. Josep Trueta of Girona
Sep 6, 2021
Breast Cancer Stage IV, Radiotherapy, Surgery Trial in France (Palbociclib, locoregional treatment)
Recruiting
- Breast Cancer Stage IV
- +2 more
- Palbociclib
- locoregional treatment
-
Angers, France
- +25 more
Sep 1, 2022
Locoregional Anesthesia Trial in Montpellier (measure of injection pressure by compuflo)
Terminated
- Locoregional Anesthesia
- measure of injection pressure by compuflo
-
Montpellier, FranceUniversity Hospital of Montpellier
Nov 8, 2022
Breast Cancer Trial in Worldwide (Artificial Intelligence and Digital Health Arm)
Not yet recruiting
- Breast Cancer
- Artificial Intelligence and Digital Health Arm
-
Heidelberg, Germany
- +3 more
Jun 1, 2022
Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))
Not yet recruiting
- Hepatocellular Carcinoma (HCC)
- Durvalumab
- +2 more
- (no location specified)
Sep 11, 2023
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023